Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Casirivimab
Asymptomatic
Emergency use authorization Experimental Antiviral Jan/23/2023
Imdevimab
Asymptomatic
Emergency use authorization Experimental Antiviral Jan/23/2023
Bamlanivimab
Asymptomatic
Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022
BNT162b2
Asymptomatic
Approved by FDA Experimental Vaccine Jun/22/2022
REGEN-COV
Asymptomatic
Emergency use authorization Experimental Antiviral Jun/03/2022
Favipiravir
Asymptomatic
Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/24/2021
Vitamin D3
Asymptomatic
Potential treatment - clinical evidence Used to treat other disease Other treatment Feb/17/2021
Traditional Indian Ayurvedic treatment regime
Asymptomatic
Potential treatment - clinical evidence Natural product Antiviral Feb/04/2021